Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: Dr Pharis Mohideen
DBV Outlines Path to Regulatory Approval of Viaskin Peanut Patch
Dave Bloom
-
2023/04/21
Are Viaskin therapies finally on the horizon?
FDA Removes Hold Allowing DBV’s Pivotal Phase 3 Peanut Patch Trial...
Dave Bloom
-
2022/12/26
The phase 3 trial of the modified Viaskin Peanut patch has been cleared for commencement.
DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...
News Wire ~ 3rd Party Press Release
-
2022/06/08
Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Viaskin Peanut Patch Therapy Delayed Further as DBV Readies Another Phase...
Dave Bloom
-
2021/12/22
The patch therapy remains in regulatory limbo.
Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...
Dave Bloom
-
2020/06/30
Company is restructuring in anticipation of delays.